Trump's Rx Price Plans May Inoculate Brands From Legislation

By John Wilkerson / November 5, 2018 at 3:00 PM
Opinions are divided over whether Democrats would work with Republicans on drug price legislation if Democrats win the House. Some say divided government presents the best opportunity for compromise and there are policies with bipartisan appeal, but others think Democrats will avoid working with the president, especially if it helps him get a legislative win on a big campaign issue, so his aggressive proposals on drug prices might have the effect of inoculating industry from drug price legislation. The president...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.